Patent · US Active

Methods of reducing risk of preterm birth

US11304962B2 · kind B2 · utility

1Cited by
19References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 30, 2021
Grant dateApr 19, 2022
Priority date—
Expiry dateJun 30, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/44
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This disclosure generally relates to methods for reducing the risk of preterm birth in a pregnant human female patient that include subcutaneous administration of HPC. The disclosure relates in part to the discovery that subcutaneous administration of HPC is actually feasible and can result in sufficient plasma levels of HPC in pregnant patients that can reduce the risk of preterm birth.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.